Allosteric regulation of deubiquitylase activity through ubiquitination

Ataxin-3, the protein responsible for spinocerebellar ataxia type-3, is a cysteine protease that specifically cleaves poly-ubiquitin chains and participates in the ubiquitin proteasome pathway. The enzymatic activity resides in the N-terminal Josephin domain. An unusual feature of ataxin-3 is its low enzymatic activity especially for mono-ubiquitinated substrates and short ubiquitin chains. However, specific ubiquitination at lysine 117 in the Josephin domain activates ataxin-3 through an unknown mechanism. Here, we investigate the effects of K117 ubiquitination on the structure and enzymatic activity of the protein. We show that covalently linked ubiquitin rests on the Josephin domain, forming a compact globular moiety and occupying a ubiquitin binding site previously thought to be essential for substrate recognition. In doing so, ubiquitination enhances enzymatic activity by locking the enzyme in an activated state. Our results indicate that ubiquitin functions both as a substrate and as an allosteric regulatory factor. We provide a novel example in which a conformational switch controls the activity of an enzyme that mediates deubiquitination.

[1]  K. Scaglione,et al.  Ubiquitin-Binding Site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23 , 2014, Nature Communications.

[2]  R. P. Menon,et al.  Enzymatic production of mono-ubiquitinated proteins for structural studies: The example of the Josephin domain of ataxin-3☆ , 2013, FEBS open bio.

[3]  K. Scaglione,et al.  Ubiquitination Regulates the Neuroprotective Function of the Deubiquitinase Ataxin-3 in Vivo* , 2013, The Journal of Biological Chemistry.

[4]  Stephen W. Fesik,et al.  Fragment-based drug discovery using NMR spectroscopy , 2013, Journal of biomolecular NMR.

[5]  Thomas M. Durcan,et al.  Ataxin-3 and Its E3 Partners: Implications for Machado–Joseph Disease , 2013, Front. Neurol..

[6]  H. Paulson Machado-Joseph disease/spinocerebellar ataxia type 3. , 2012, Handbook of clinical neurology.

[7]  Carlos A. Matos,et al.  Polyglutamine diseases: The special case of ataxin-3 and Machado–Joseph disease , 2011, Progress in Neurobiology.

[8]  P. Loll,et al.  Crystal Structure of a Josephin-Ubiquitin Complex , 2010, The Journal of Biological Chemistry.

[9]  H. Paulson,et al.  Activity and Cellular Functions of the Deubiquitinating Enzyme and Polyglutamine Disease Protein Ataxin-3 Are Regulated by Ubiquitination at Lysine 117* , 2010, The Journal of Biological Chemistry.

[10]  Giuseppe Nicastro,et al.  Understanding the Role of the Josephin Domain in the PolyUb Binding and Cleavage Properties of Ataxin-3 , 2010, PloS one.

[11]  Franca Fraternali,et al.  Josephin domain of ataxin‐3 contains two distinct ubiquitin‐binding sites , 2009, Biopolymers.

[12]  D. Komander The emerging complexity of protein ubiquitination. , 2009, Biochemical Society transactions.

[13]  David Komander,et al.  Breaking the chains: structure and function of the deubiquitinases , 2009, Nature Reviews Molecular Cell Biology.

[14]  Wendy A. Warr,et al.  Fragment-based drug discovery , 2009, J. Comput. Aided Mol. Des..

[15]  Keith D Wilkinson,et al.  Polyubiquitin binding and disassembly by deubiquitinating enzymes. , 2009, Chemical reviews.

[16]  H. Paulson,et al.  Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin‐3 , 2009, The EMBO journal.

[17]  Zhijian J. Chen,et al.  Nonproteolytic functions of ubiquitin in cell signaling. , 2009, Molecular cell.

[18]  Dmitri I. Svergun,et al.  Electronic Reprint Applied Crystallography Dammif, a Program for Rapid Ab-initio Shape Determination in Small-angle Scattering Applied Crystallography Dammif, a Program for Rapid Ab-initio Shape Determination in Small-angle Scattering , 2022 .

[19]  H. Paulson,et al.  The Deubiquitinating Enzyme Ataxin-3, a Polyglutamine Disease Protein, Edits Lys63 Linkages in Mixed Linkage Ubiquitin Chains* , 2008, Journal of Biological Chemistry.

[20]  Daniel C. Scott,et al.  Structural Insights into NEDD8 Activation of Cullin-RING Ligases: Conformational Control of Conjugation , 2008, Cell.

[21]  D. Geschwind,et al.  Functional genomics and biochemical characterization of the C. elegans orthologue of the Machado‐Joseph disease protein ataxin‐3 , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  Giuseppe Nicastro,et al.  Structure validation of the Josephin domain of ataxin-3: Conclusive evidence for an open conformation , 2006, Journal of biomolecular NMR.

[23]  H. Paulson,et al.  CHIP Suppresses Polyglutamine Aggregation and Toxicity In Vitro and In Vivo , 2005, The Journal of Neuroscience.

[24]  P. Robinson,et al.  E3 ubiquitin ligases. , 2005, Essays in biochemistry.

[25]  Dmitri I Svergun,et al.  Global rigid body modeling of macromolecular complexes against small-angle scattering data. , 2005, Biophysical journal.

[26]  Giuseppe Nicastro,et al.  The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. Nicastro,et al.  Solution structure of the Josephin domain of Ataxin-3 , 2005 .

[28]  Keiji Tanaka,et al.  Co-chaperone CHIP Associates with Expanded Polyglutamine Protein and Promotes Their Degradation by Proteasomes* , 2005, Journal of Biological Chemistry.

[29]  Barrington G. Burnett,et al.  The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Letter to the Editor: Assignment of the 1H, 13C, and 15N resonances of the Josephin domain of human ataxin-3 , 2004, Journal of biomolecular NMR.

[31]  Michelle K. M. Chow,et al.  Structural and functional analysis of the Josephin domain of the polyglutamine protein ataxin-3. , 2004, Biochemical and biophysical research communications.

[32]  Manuela M. Santos,et al.  Genomic structure, promoter activity, and developmental expression of the mouse homologue of the Machado-Joseph disease (MJD) gene. , 2004, Genomics.

[33]  Thomas Lengauer,et al.  Structural and functional analysis of ataxin-2 and ataxin-3. , 2004, European journal of biochemistry.

[34]  T. O'Brien,et al.  Fragment-based drug discovery. , 2004, Journal of medicinal chemistry.

[35]  H. Ishimoto,et al.  Molecular clearance of ataxin‐3 is regulated by a mammalian E4 , 2004, The EMBO journal.

[36]  H. Paulson,et al.  Poly-ubiquitin Binding by the Polyglutamine Disease Protein Ataxin-3 Links Its Normal Function to Protein Surveillance Pathways* , 2004, Journal of Biological Chemistry.

[37]  Barrington G. Burnett,et al.  The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. , 2003, Human molecular genetics.

[38]  Dmitri I. Svergun,et al.  PRIMUS: a Windows PC-based system for small-angle scattering data analysis , 2003 .

[39]  Annalisa Pastore,et al.  Domain architecture of the polyglutamine protein ataxin‐3: a globular domain followed by a flexible tail , 2003, FEBS letters.

[40]  Muyang Li,et al.  Crystal Structure of a UBP-Family Deubiquitinating Enzyme in Isolation and in Complex with Ubiquitin Aldehyde , 2002, Cell.

[41]  Hideo Takahashi,et al.  A novel NMR method for determining the interfaces of large protein–protein complexes , 2000, Nature Structural Biology.

[42]  S. H. Wilson,et al.  Backbone dynamics and refined solution structure of the N-terminal domain of DNA polymerase beta. Correlation with DNA binding and dRP lyase activity. , 2000, Journal of molecular biology.

[43]  Martin Rechsteiner,et al.  Recognition of the polyubiquitin proteolytic signal , 2000, The EMBO journal.

[44]  R. Stein,et al.  Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes. , 1998, Biochemistry.

[45]  Shigenobu Nakamura,et al.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1 , 1994, Nature Genetics.

[46]  D. M. Schneider,et al.  Fast internal main-chain dynamics of human ubiquitin. , 1992, Biochemistry.

[47]  W. Wooster,et al.  Crystal structure of , 2005 .